Peter Abraham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter Abraham has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Anthony E. Bishay
3 shared publications- Arvin Raj Wali
Department of Neurosurgery, University of California, San Diego
3 shared publications - David Rafael Santiago-Dieppa
University of California, San Diego, United States
3 shared publications Dorathy Tamayo-Murillo
Department of Radiology, University of California, San Diego, 200 West Arbor Dr, San Diego, CA 92103; School of Medicine, University of California, San Diego, La Jolla, California; Department of Radiology, Harvard School of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut
3 shared publicationsIsabel G. Newton
Department of Radiology, University of California, San Diego, 200 West Arbor Dr, San Diego, CA 92103; School of Medicine, University of California, San Diego, La Jolla, California; Department of Radiology, Harvard School of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut
3 shared publications- Michael G. Brandel
Department of Neurosurgery University of California San Diego San Diego California USA
3 shared publications
Latest Publications
- 19 December 2023
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 21 (7) , 989-990
Reply
- 19 December 2023
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 21 (7) , 989-990
Reply
- 1 November 2023
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (11) , e230008
Social Determinants of Health in Imaging-based Cancer Screening: A Case-based Primer with Strategies for Care Improvement
Health disparities, preventable differences in the burden of disease and disease outcomes often experienced by socially disadvantaged populations, can be found in nearly all areas of radiology, including emergency radiology, neuroradiology, nuclear medicine, image-guided interventions, and imaging-based cancer screening. Disparities in imaging-based cancer screening are especially noteworthy given the far-reaching population health impact. The social determinants of health (SDoH) play an important role in disparities in cancer screening and outcomes. Through improved understanding of how SDoH can drive differences in health outcomes in radiology, radiologists can effectively provide patient-centered, high-quality, and equitable care. Radiologists and radiology practices can become active partners in efforts to assist patients along their imaging journey and overcome existing barriers to equitable cancer screening care for traditionally marginalized populations. As radiology exists at the intersection of diagnostic imaging, image-guided diagnostic intervention, and image-guided treatment, radiologists are uniquely positioned to design these strategies. Cost-effective and socially conscious strategies that address barriers to equitable care can improve both public health and equitable health outcomes. Potential strategies include championing supportive health policy, reducing out-of-pocket costs, increasing price transparency, improving education and outreach efforts, ensuring that appropriate language translation services are available, providing individualized assistance with appointment scheduling, and offering transportation assistance and childcare. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material.
- 1 November 2023
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (11) , e230008
Social Determinants of Health in Imaging-based Cancer Screening: A Case-based Primer with Strategies for Care Improvement
Health disparities, preventable differences in the burden of disease and disease outcomes often experienced by socially disadvantaged populations, can be found in nearly all areas of radiology, including emergency radiology, neuroradiology, nuclear medicine, image-guided interventions, and imaging-based cancer screening. Disparities in imaging-based cancer screening are especially noteworthy given the far-reaching population health impact. The social determinants of health (SDoH) play an important role in disparities in cancer screening and outcomes. Through improved understanding of how SDoH can drive differences in health outcomes in radiology, radiologists can effectively provide patient-centered, high-quality, and equitable care. Radiologists and radiology practices can become active partners in efforts to assist patients along their imaging journey and overcome existing barriers to equitable cancer screening care for traditionally marginalized populations. As radiology exists at the intersection of diagnostic imaging, image-guided diagnostic intervention, and image-guided treatment, radiologists are uniquely positioned to design these strategies. Cost-effective and socially conscious strategies that address barriers to equitable care can improve both public health and equitable health outcomes. Potential strategies include championing supportive health policy, reducing out-of-pocket costs, increasing price transparency, improving education and outreach efforts, ensuring that appropriate language translation services are available, providing individualized assistance with appointment scheduling, and offering transportation assistance and childcare. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material.
- 18 May 2023
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 20 (7) , 652-666
An Upstream Reparative Justice Framework for Improving Diversity in Radiology
- 18 May 2023
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 20 (7) , 652-666
An Upstream Reparative Justice Framework for Improving Diversity in Radiology
- 19 February 2023
- Published by Elsevier in Academic Radiology
- Vol. 30 (4) , 658-665
Change Management Strategies Toward Dismantling Race-Based Structural Barriers in Radiology
- 19 February 2023
- Published by Elsevier in Academic Radiology
- Vol. 30 (4) , 658-665
Change Management Strategies Toward Dismantling Race-Based Structural Barriers in Radiology
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (1) , 218-219
The Digital Divide in Radiology: Computer Use for Health Care–related Tasks and Breast Cancer Screening
Reliance on digital patient portals and online scheduling may exacerbate existing health disparities in breast cancer screening.
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (1) , 218-219
The Digital Divide in Radiology: Computer Use for Health Care–related Tasks and Breast Cancer Screening
Reliance on digital patient portals and online scheduling may exacerbate existing health disparities in breast cancer screening.
- Open Access
- 7 April 2022
- Published by MDPI AG in Tomography
- Vol. 8 (2) , 1060-1065
18F-FES PET/CT Improves the Detection of Intraorbital Metastases in Estrogen-Receptor-Positive Breast Cancer: Two Representative Cases and Review of the Literature
Orbital metastases are a rare but life-altering complication in cancer. Most commonly seen in breast cancer, metastases to the optic nerves or extraocular muscles can have a devastating impact on visual acuity and quality of life. Hormone receptor status plays a central role in metastatic breast cancer treatment, with endocrine therapy often representing first-line therapy in hormone-receptor-positive cancers. Staging and treatment response evaluation with positron emission tomography (PET) computed tomography (CT) imaging with 18F-fluorodeoxyglucose (18F-FDG) is limited by high physiologic uptake in the intracranial and intraorbital compartments. Thus, traditional staging scans with 18F-FDG PET/CT may under-detect intraorbital and intracranial metastatic disease and inaccurately evaluate active metastatic disease burden. In comparison, 18F-fluoroestradiol (18F-FES) is a novel estrogen-receptor-specific PET radiotracer, which more accurately assesses the intracranial and intraorbital compartments in patients with estrogen-receptor-positive (ER+) cancers than 18F-FDG, due to lack of physiologic background activity in these regions. We present two cases of breast cancer patients with orbital metastases confirmed on MR imaging who underwent PET/CT imaging with 18F-FES and 18F-FDG. Multimodality imaging with 18F-FES PET/CT offers higher detection sensitivity of orbital metastases, compared with traditional 18F-FDG PET/CT imaging, and can improve the assessment of treatment response in patients with estrogen-receptor-positive (ER+) cancers.
- 7 April 2022
- Published by MDPI AG in Tomography
- Vol. 8 (2) , 1060-1065
Open Access18F-FES PET/CT Improves the Detection of Intraorbital Metastases in Estrogen-Receptor-Positive Breast Cancer: Two Representative Cases and Review of the Literature
Orbital metastases are a rare but life-altering complication in cancer. Most commonly seen in breast cancer, metastases to the optic nerves or extraocular muscles can have a devastating impact on visual acuity and quality of life. Hormone receptor status plays a central role in metastatic breast cancer treatment, with endocrine therapy often representing first-line therapy in hormone-receptor-positive cancers. Staging and treatment response evaluation with positron emission tomography (PET) computed tomography (CT) imaging with 18F-fluorodeoxyglucose (18F-FDG) is limited by high physiologic uptake in the intracranial and intraorbital compartments. Thus, traditional staging scans with 18F-FDG PET/CT may under-detect intraorbital and intracranial metastatic disease and inaccurately evaluate active metastatic disease burden. In comparison, 18F-fluoroestradiol (18F-FES) is a novel estrogen-receptor-specific PET radiotracer, which more accurately assesses the intracranial and intraorbital compartments in patients with estrogen-receptor-positive (ER+) cancers than 18F-FDG, due to lack of physiologic background activity in these regions. We present two cases of breast cancer patients with orbital metastases confirmed on MR imaging who underwent PET/CT imaging with 18F-FES and 18F-FDG. Multimodality imaging with 18F-FES PET/CT offers higher detection sensitivity of orbital metastases, compared with traditional 18F-FDG PET/CT imaging, and can improve the assessment of treatment response in patients with estrogen-receptor-positive (ER+) cancers.
- 1 July 2021
- Published by Elsevier in Academic Radiology
- Vol. 28 (7) , 903-910
Reducing Health Disparities in Radiology Through Social Determinants of Health: Lessons From the COVID-19 Pandemic
- 1 July 2021
- Published by Elsevier in Academic Radiology
- Vol. 28 (7) , 903-910
Reducing Health Disparities in Radiology Through Social Determinants of Health: Lessons From the COVID-19 Pandemic
- 1 July 2021
- Published by Elsevier in Academic Radiology
- Vol. 28 (7) , 893-902
The Roots of Structural Racism in the United States and their Manifestations During the COVID-19 Pandemic
- 1 July 2021
- Published by Elsevier in Academic Radiology
- Vol. 28 (7) , 893-902
The Roots of Structural Racism in the United States and their Manifestations During the COVID-19 Pandemic
- 1 July 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (1) , 239-243
Case 279: Central-Variant Posterior Reversible Encephalopathy Syndrome
This patient’s clinical and radiologic findings, combined with her rapid normalization, was consistent with central-variant posterior reversible encephalopathy syndrome. HistoryA 25-year-old woman with recently diagnosed systemic lupus erythematosus and class IV lupus nephritis confirmed with biopsy and treated with mycophenolate mofetil presented with a 2-day hist...
- 1 July 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (1) , 239-243
Case 279: Central-Variant Posterior Reversible Encephalopathy Syndrome
This patient’s clinical and radiologic findings, combined with her rapid normalization, was consistent with central-variant posterior reversible encephalopathy syndrome. HistoryA 25-year-old woman with recently diagnosed systemic lupus erythematosus and class IV lupus nephritis confirmed with biopsy and treated with mycophenolate mofetil presented with a 2-day hist...
- 1 March 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 294 (3) , 714-715
Case 279
HistoryA 25-year-old woman with recently diagnosed systemic lupus erythematosus and class IV lupus nephritis confirmed with biopsy and treated with mycophenolate mofetil presented with a 2-day hist...
- 1 March 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 294 (3) , 714-715
Case 279
HistoryA 25-year-old woman with recently diagnosed systemic lupus erythematosus and class IV lupus nephritis confirmed with biopsy and treated with mycophenolate mofetil presented with a 2-day hist...